Bharat Biotech's Covaxin is being tested on children as young as two years old. The results of these trials will be known in two-to-three months, AIIMS Delhi chief Dr Randeep Guleria has said.
source https://www.ndtv.com/india-news/antibodies-found-in-many-children-3rd-wave-may-not-affect-aiims-chief-2470929
source https://www.ndtv.com/india-news/antibodies-found-in-many-children-3rd-wave-may-not-affect-aiims-chief-2470929
Comments
Post a Comment